Stock MoversStock Movers

Deutz Buy, Astrazeneca's Trial, Computacenter Up

View descriptionShare
 

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Deutz agreed to buy military vehicle maker Flensburger Fahrzeugbau Gesellschaft mbH for €1.6 billion ($1.8 billion), expanding further into the defense sector to benefit from Europe’s rearmament drive.
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.
- Computacenter expects first-half adjusted profit before tax to be double the prior year’s first-half figure of £81.5m, following 2Q performance ahead of expectations.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Stock Movers

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Su 
Social links
Follow podcast
Recent clips
Browse 2,556 clip(s)